Page last updated: 2024-10-26

3,3'-diindolylmethane and Osteoporosis, Postmenopausal

3,3'-diindolylmethane has been researched along with Osteoporosis, Postmenopausal in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, TY1
Pang, WJ1
Yang, GS1

Other Studies

1 other study available for 3,3'-diindolylmethane and Osteoporosis, Postmenopausal

ArticleYear
3,3'-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice.
    Journal of pharmacological sciences, 2015, Volume: 127, Issue:1

    Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Female; Humans; Indoles; Mice; Osteoclasts;

2015